Best Grants for HIV / AIDS in Virgin Islands

Research institutions conducting substance use, addiction, and HIV studies in the Virgin Islands and other eligible U.S. locations can apply for NIH core center funding to build transformative research centers. Focused on advancing addiction and HIV science, the US Dept. of Health & Human Services: National Institutes of Health supports shared resources, interdisciplinary collaboration, and early-career investigators.

The Academic Research Enhancement Award (AREA) supports small-scale research grants for institutions with limited NIH funding, emphasizing biomedical research experiences for undergraduates. Eligible institutions must award baccalaureate science degrees and have received no more than $6 million in NIH support over the past seven years. This initiative aims to enhance the research environment at these institutions, fostering student involvement in research activities.

The NIDCD is offering funding to advance HIV/AIDS research, particularly focusing on areas related to communication disorders. This initiative supports low-risk clinical trials and encourages researchers to align their proposals with high priority topics identified by the NIH Office of AIDS Research. Applications must be submitted by the local deadline, with optional Letters of Intent due 30 days prior to the proposal deadline. This opportunity aims to enhance understanding and treatment in this crucial health area.

Research institutions and similar organizations studying HIV-related biological, behavioral, or social mechanisms affecting NIDDK-relevant organs can seek up to US $275,000 for pilot projects in the Virgin Islands and other U.S. locations. US Dept. of Health & Human Services: National Institutes of Health supports work on HIV comorbidities, coinfections, complications, and viral reservoirs.

Researchers and investigators conducting innovative HIV and substance use or substance use disorder studies in the Virgin Islands can seek high-risk, high-reward funding through the National Institutes of Health. US Dept. of Health & Human Services: National Institutes of Health supports pioneering biomedical and behavioral HIV research, including early stage investigators, with awards ranging from US $350,000 - US $700,000.

Research institutions and clinical trial networks focused on HIV treatment and prevention for infants, children, adolescents, young adults, and maternal populations in the Virgin Islands and other U.S. territories can pursue this upcoming opportunity, with awards up to US $30,000,000. With a mission to advance child and maternal health, National Institutes of Health will fund collaborative HIV clinical trials and related comorbidity studies.

Research institutions and multidisciplinary teams in the Virgin Islands and other eligible U.S. jurisdictions can apply for National Institutes of Health funding, up to US $8,000,000, to study hepatitis B cure strategies in people living with HIV and HBV. Projects must use observational cohorts and existing clinical data or sample repositories.

Public health agencies and research-focused organizations working on HIV / AIDS in the Virgin Islands can seek funding to conduct ongoing bio-behavioral surveillance of populations disproportionately affected by HIV. With a mission to monitor risk behaviors and prevention uptake, Centers for Disease Control & Prevention supports data collection, HIV testing, and linkage to prevention or care services.

Research institutions and multidisciplinary scientific teams in the Virgin Islands and other eligible U.S. territories can apply for National Institutes of Health support to establish Centers for Structural Biology of HIV and other infectious diseases. Funding supports high-resolution structural analyses, computational modeling, and structure-guided design of molecules to develop new diagnostics and treatments for priority infections.

Grants from the National Institutes of Health help Virgin Islands organizations conduct pilot and feasibility studies on substance use and HIV prevention, treatment, and services research. Eligible projects can develop or adapt interventions, test acceptability and feasibility, or create measures and methods, with required engagement of end users such as policymakers, practitioners, and community members.

Research institutions and early-career investigators studying HIV-related chronic conditions, coinfections, and comorbidities can apply for funding that supports pioneering HIV / AIDS research, including work relevant to the Virgin Islands. Grants from US Dept. of Health & Human Services: National Institutes of Health advance innovative HIV prevention and treatment strategies, especially for pediatric and maternal populations.

Virgin Islands HIV/AIDS research organizations can access funding through the National Institutes of Health to study how HIV immunotherapies affect central nervous system outcomes in people with HIV. This R21/R33 opportunity supports biphasic projects evaluating mechanisms, benefits, and risks in the CNS, with awards up to US $2,000,000 for qualified investigators and teams.

Research institutions and clinical organizations conducting HIV and HIV-associated disease clinical trials can access funding through the National Institutes of Health in the Virgin Islands and other eligible locations. Grants support Clinical Trials Units that run randomized prevention and treatment studies, implementation research, and maintain clinical research sites with the capacity to recruit and retain relevant participants.

Research institutions with capacity to run HIV clinical trials and advanced data systems in the Virgin Islands can access funding through the National Institutes of Health to serve as Statistical and Data Management Centers. Awards support leadership in trial design, data collection and integration, monitoring, analysis, and regulatory-compliant data management for HIV and related studies.

Research institutions and clinical laboratories in the Virgin Islands working on HIV/AIDS prevention and treatment can apply for National Institutes of Health support to serve as Clinical Trials Network Laboratory Centers. Funding supports laboratory infrastructure, regulatory-standard testing, data systems, and advanced assays for HIV clinical trials and implementation research, including work with U.S. territories.

Research institutions and clinical trial networks focusing on HIV/AIDS prevention, treatment, and implementation science can access funding via the National Institutes of Health to lead Clinical Trials Network Leadership and Operations Centers. Centers will guide agendas on therapeutics, biomedical and immune-based prevention, and care for adults, adolescents, maternal, and pediatric populations, including work benefiting the Virgin Islands.

The Ryan White HIV/AIDS Program Part B AIDS Drug Assistance Program Training and Technical Assistance aims to enhance the capacity of ADAPs. By providing essential tools and expert guidance, the program seeks to improve health outcomes for individuals living with HIV in an evolving healthcare landscape. This initiative is funded by the US HHS through the Health Resources & Services Administration, ensuring support and resources are effectively allocated to meet the needs of vulnerable populations.

The Ryan White HIV/AIDS Program Part D provides supplemental funding aimed at enhancing the infrastructure and capacity of organizations to deliver high-quality, family-centered HIV care services. This initiative focuses on two key areas: HIV Care Innovation and Infrastructure Development, ensuring improved access to essential services for women, infants, children, and youth affected by HIV.

This project aims to enhance health outcomes for women living with HIV in the South by integrating HIV care with comprehensive women's health services through coordinated Clinic and Community Collaboratives. By funding organizations to implement targeted strategies such as culturally responsive services and learning collaboratives, the initiative seeks to improve access to essential health services, increase the number of women initiating rapid ART, and foster sustainable healthcare models that address the unique needs of this population.

This funding opportunity aims to enhance a web-based ordering portal for distributing 1.5 million HIV and STI self-tests to high-burden communities. By optimizing access to these self-tests, the initiative seeks to raise awareness, prevent new infections, and improve the health outcomes of users, thereby contributing to better overall public health and wellbeing.

The HIV Care Grant Program aims to enhance access to comprehensive, high-quality HIV care and treatment for low-income individuals in Pacific Island territories. Funded by the US HHS: Health Resources & Services Administration (HRSA), this initiative supports states and territories in developing effective systems of care, ensuring that those affected by HIV receive the necessary treatment and support to improve health outcomes.

The Ryan White HIV/AIDS Program Part B Supplemental Grant aims to provide essential funding to support HIV care and treatment services across states and territories. This program supplements existing formula-based funding from the RWHAP Part B and ADAP, improving access to necessary resources for those affected by HIV/AIDS. By enhancing support structures, it addresses critical healthcare needs, ensuring better health outcomes for vulnerable populations.

The HIV Care Grant Program, funded by the US HHS: Health Resources & Services Administration (HRSA), aims to enhance access to high-quality HIV care and treatment for low-income individuals. This initiative supports states and territories in developing comprehensive systems to address the needs of those living with HIV. By providing essential resources, the program seeks to improve health outcomes and ensure that vulnerable populations receive the necessary support and services.

The Ryan White HIV/AIDS Program Part C Capacity Development Program aims to enhance the capabilities of community-based organizations, focusing on improving health outcomes and decreasing HIV transmission. This initiative supports individuals who have not yet accessed regular HIV care, emphasizing innovative care solutions and infrastructure development to address these critical needs.

State and territorial health agencies in the Virgin Islands and other U.S. jurisdictions can apply for HIV/AIDS treatment funding to prevent, reduce, or eliminate AIDS Drug Assistance Program (ADAP) waiting lists and shortfalls. The Health Resources & Services Administration offers up to US $10,000,000 in Emergency Relief Funds to stabilize and expand ADAP services.